LINCOLN PHARMACEUTICALS LTD. - 531633 - Shareholding for the Period Ended September 30, 2020
Lincoln Pharmaceuticals Ltd has submitted to BSE the Shareholding Pattern for the Period Ended September 30, 2020. For more details, kindly Click here LINCOLN PHARMACEUTICALS LTD. - 531633 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Certificate under Regulation 74 (5) of SEBI (Depositories and Participants) Regulations, 2018 for the Quarter Ended September 30, 2020. LINCOLN PHARMACEUTICALS LTD. - 531633 - Statement Of Investor Complaints For The Quarter Ended September 2020
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- NIREN DESAIDesignation :- Company Secretary and Compliance Officer LINCOLN PHARMACEUTICALS LTD. - 531633 - Disclosure of Voting results of AGM (Regulation 44(3) of SEBI (LODR) Regulations, 2015)
Lincoln Pharmaceuticals Ltd has informed BSE regarding the details of Voting results of AGM, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. Kindly Click here LINCOLN PHARMACEUTICALS LTD. - 531633 - Shareholder Meeting / Postal Ballot-Scrutinizer''s Report
Pursuant to the provisions of Regulation 44 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that 26th Annual General Meeting of the company was held on Wednesday, September 30, 2020 at 11:00 a.m. through Video Conferencing (VC) / Other Audio Visual Means (OAVM) in accordance with the relevant circulars issued by the Ministry of Corporate Affairs and the Securities and Exchange Board of India. We enclose herewith the details of the results of voting held through remote e-voting and e-voting at the AGM along with scrutinizer's report on e-voting. A copy of the same is also being placed on the Company''s website. LINCOLN PHARMACEUTICALS LTD. - 531633 - Shareholder Meeting / Postal Ballot-Outcome of AGM
In compliance of various circulars issued by Ministry of Corporate Affairs and Securities and Exchange Board of India, the 26th AGM of the Company was held today i.e. on Wednesday, September 30, 2020 through Video Conferencing ('VC') / Other Audio Visual Means (OAVM) to seek the approval of members of the Company on resolutions set out in the Notice convening the Meeting. LINCOLN PHARMACEUTICALS LTD. - 531633 - Closure of Trading Window
Pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015 read with SEBI (Prohibition of Insider Trading) (Amendment) Regulations, 2018 and Code of Practices & Procedures for Fair Disclosure of Unpublished Price Sensitive Information adopted by the Company it is informed that the Trading Window for dealing in securities of the Company shall remain closed from October 01, 2020 till Forty Eight Hours after the declaration of Un-Audited Financial Results of the Company for the Quarter and Half-Year Ended on September 30, 2020. LINCOLN PHARMACEUTICALS LTD. - 531633 - Announcement under Regulation 30 (LODR)-Newspaper Publication
We enclosed herewith the copies of published newspaper advertisement with respect to notice of the court / NCLT conveyed meeting of equity shareholders, secured creditors and un-secured creditors in connection with the scheme of amalgamation of Lincoln Parenteral Limited (Transferor Company) and Lincoln Pharmaceuticals Limited (Transferee Company) and their respective shareholders and creditors. LINCOLN PHARMACEUTICALS LTD. - 531633 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Published newspaper advertisement with respect to the Notice of 2Gth Annual General Meeting of the Company. LINCOLN PHARMACEUTICALS LTD. - 531633 - Intimation Of The Book Closure
Register of Members and Share Transfer Books of the Company will remain closed from Monday, September 21, 2020 to Wednesday, September 30, 2020 (both days inclusive) for the purpose of 26th Annual General Meeting of the Company.